These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32613638)

  • 1. No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
    Caselli D; Chironna M; Loconsole D; Nigri L; Mazzotta F; Bonamonte D; Aricò M
    Br J Dermatol; 2020 Oct; 183(4):784-785. PubMed ID: 32613638
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient.
    Santonja C; Heras F; Núñez L; Requena L
    Br J Dermatol; 2020 Oct; 183(4):778-780. PubMed ID: 32585767
    [No Abstract]   [Full Text] [Related]  

  • 3. Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series.
    Rizzoli L; Collini L; Magnano M; Termine S; Barcelli R; Infusino SD; Bauer P; Rech G; Girardelli CR; Balestri R
    Br J Dermatol; 2020 Oct; 183(4):782-784. PubMed ID: 32613620
    [No Abstract]   [Full Text] [Related]  

  • 4. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
    Piccolo V; Neri I; Manunza F; Mazzatenta C; Bassi A
    Int J Dermatol; 2020 Aug; 59(8):1026-1027. PubMed ID: 32496583
    [No Abstract]   [Full Text] [Related]  

  • 5. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
    Le Cleach L; Dousset L; Assier H; Fourati S; Barbarot S; Boulard C; Bourseau Quetier C; Cambon L; Cazanave C; Colin A; Kostrzewa E; Lesort C; Levy Roy A; Lombart F; Marco-Bonnet J; Monfort JB; Samimi M; Tardieu M; Wolkenstein P; Sbidian E; Beylot-Barry M;
    Br J Dermatol; 2020 Nov; 183(5):866-874. PubMed ID: 32628270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chilblain-like lesions during the COVID-19 pandemic: early or late sign?
    Recalcati S; Fantini F
    Int J Dermatol; 2020 Aug; 59(8):e268-e269. PubMed ID: 32572958
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous lesions in a patient with COVID-19: are they related?
    Ahouach B; Harent S; Ullmer A; Martres P; Bégon E; Blum L; Tess O; Bachmeyer C
    Br J Dermatol; 2020 Aug; 183(2):e31. PubMed ID: 32353170
    [No Abstract]   [Full Text] [Related]  

  • 8. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
    Kanitakis J; Lesort C; Danset M; Jullien D
    J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions.
    Denina M; Pellegrino F; Morotti F; Coppo P; Bonsignori IM; Garazzino S; Ravanini P; Avolio M; Cavallo R; Bertolotti L; Felici E; Acucella G; Montin D; Rabbone I; Licciardi F
    J Am Acad Dermatol; 2020 Dec; 83(6):1751-1753. PubMed ID: 32781180
    [No Abstract]   [Full Text] [Related]  

  • 10. When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection.
    Damsky W; Peterson D; King B
    J Am Acad Dermatol; 2020 Sep; 83(3):e269-e270. PubMed ID: 32565206
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.
    Battesti G; El Khalifa J; Abdelhedi N; Ferre V; Bouscarat F; Picard-Dahan C; Brunet-Possenti F; Collin G; Lavaud J; Le Bozec P; Rousselot M; Tournier A; Lheure C; Couvelard A; Hacein-Bey-Abina S; Abina AM; Charpentier C; Mignot S; Nicaise P; Descamps D; Deschamps L; Descamps V
    J Am Acad Dermatol; 2020 Oct; 83(4):1219-1222. PubMed ID: 32622895
    [No Abstract]   [Full Text] [Related]  

  • 12. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.
    Colonna C; Genovese G; Monzani NA; Picca M; Boggio F; Gianotti R; Marzano AV
    J Am Acad Dermatol; 2020 Sep; 83(3):965-969. PubMed ID: 32534082
    [No Abstract]   [Full Text] [Related]  

  • 13. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
    Kerber AA; Soma DB; Youssef MJ
    Int J Dermatol; 2020 Aug; 59(8):1024-1025. PubMed ID: 32496578
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of association between chilblains outbreak and severe acute respiratory syndrome coronavirus 2: Histologic and serologic findings from a new immunoassay.
    Hébert V; Duval-Modeste AB; Joly P; Lemée V; Cellier L; Jouen F; Veber B; Drouot L; Boyer O
    J Am Acad Dermatol; 2020 Nov; 83(5):1434-1436. PubMed ID: 32682889
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perniosis-like skin lesions during the COVID-19 epidemic].
    Monte Serrano J; Cruañes Monferrer J; Matovelle Ochoa C; García-Gil MF
    An Pediatr (Engl Ed); 2020 Jun; 92(6):378-380. PubMed ID: 32418860
    [No Abstract]   [Full Text] [Related]  

  • 17. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The explosion of new coronavirus tests that could help to end the pandemic.
    Guglielmi G
    Nature; 2020 Jul; 583(7817):506-509. PubMed ID: 32681157
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymorphic cutaneous manifestations of COVID-19 infection in a single viral host.
    Patel N; Kho J; Smith KE; Ahmed A; Van den Abbeele K; Mandal AKJ; Missouris CG
    Int J Dermatol; 2020 Sep; 59(9):1149-1150. PubMed ID: 32686096
    [No Abstract]   [Full Text] [Related]  

  • 20. How should a positive PCR test result for COVID-19 in an asymptomatic individual be interpreted and managed?
    Esteve C; Catherine FX; Chavanet P; Blot M; Piroth L
    Med Mal Infect; 2020 Nov; 50(8):633-638. PubMed ID: 33022291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.